TMBIM6 and breast carcinoma: Furthermore, miR‐302d‐3p‐mediated regulation of TMBIM6 has been implicated in breast cancer cell viability, migration, and apoptosis, highlighting the potential therapeutic implications of targeting TMBIM6 and its associated downstream signaling pathways.41